ConductScience.org, home

Paper41007616

In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration.

Kocab AJ and 6 others. Biomedicines, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. Papers, record 41007616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007616

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration.
PubMed
Journal
Biomedicines
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-10-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kocab AJAndrew Jhttps://orcid.org/0000-0001-6069-2166
2Cano MMarisol
3Bacellar-Galdino MMariannahttps://orcid.org/0000-0002-8765-4466
4Jamison JAJeffrey Ahttps://orcid.org/0009-0000-3472-3467
5Brock WJWilliam J
6Zacks DNDavid N
7Handa JTJames Thttps://orcid.org/0000-0003-1314-1745

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R42 EY029625NEI NIH HHSUnited StatesR42EY029625PubMed and NIH
5R42EY029625-23NIH HHSUnited StatesR42EY029625PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12409504Pathologic features of senile macular degeneration.Ophthalmology1985https://conductscience.org/library/papers/2409504PubMed
21553220Histologic features of the early stages of age-related macular degeneration. A statistical analysis.Ophthalmology1992https://conductscience.org/library/papers/1553220PubMed
340490177Extracellular GMFB activates the non-canonical FAS-FAF1 pathway to induce lysosomal dysfunction in early diabetic retinopathy.Int J Biol Macromol2025https://conductscience.org/library/papers/40490177PubMed
412427055The role of apoptosis in age-related macular degeneration.Arch Ophthalmol2002https://conductscience.org/library/papers/12427055PubMed
511714783Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors.J Immunol2001https://conductscience.org/library/papers/11714783PubMed
631350409A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration.Nat Commun2019https://conductscience.org/library/papers/31350409PubMed
727849168Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.J Immunol2016https://conductscience.org/library/papers/27849168PubMed
822911474Enhanced apoptosis in retinal pigment epithelium under inflammatory stimuli and oxidative stress.Apoptosis2012https://conductscience.org/library/papers/22911474PubMed
920505194Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration.Invest Ophthalmol Vis Sci2010https://conductscience.org/library/papers/20505194PubMed
1037865470Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.Lancet2023https://conductscience.org/library/papers/37865470PubMed
1119850829Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor.Invest Ophthalmol Vis Sci2010https://conductscience.org/library/papers/19850829PubMed
1235921555Mitophagy initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell heterogeneity.Autophagy2023https://conductscience.org/library/papers/35921555PubMed
1335160044Cell Death in AMD: The Rationale for Targeting Fas.J Clin Med2022https://conductscience.org/library/papers/35160044PubMed
147530337Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.Nature1995https://conductscience.org/library/papers/7530337PubMed
157530335Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature1995https://conductscience.org/library/papers/7530335PubMed
167530336Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.Nature1995https://conductscience.org/library/papers/7530336PubMed
1737696275Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.Lancet2023https://conductscience.org/library/papers/37696275PubMed
1834448806Hyperreflective Foci, Optical Coherence Tomography Progression Indicators in Age-Related Macular Degeneration, Include Transdifferentiated Retinal Pigment Epithelium.Invest Ophthalmol Vis Sci2021https://conductscience.org/library/papers/34448806PubMed
1918769672Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice.PLoS One2008https://conductscience.org/library/papers/18769672PubMed
2032560057EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration.Int J Mol Sci2020https://conductscience.org/library/papers/32560057PubMed

See all 46 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41516080Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies.Int J Mol Sci2025https://conductscience.org/library/papers/41516080

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007616

GET https://conductscience.org/api/papers/v1/41007616/references?page=2